Psychiatric Genomics Consortium cohort

Aliases

COGS, GPC, International Suicide Genetics Consortium, PGC, PGC investigators, PGC12, Psychiatr. GWAS Consort. Steer. Comm., Suicide Working Group of the Psychiatric Genomics Consortium, internal PGC datasets

Related entities (36)

Mentioned in (66)

Papers in which this entity is mentioned.

• Massively parallel reporter assay investigates shared genetic variants of eight psychiatric disorders. (2025)
• Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder. (2025)
• Clinical, genomic, and neurophysiological correlates of lifetime suicide attempts among individuals with alcohol dependence. (2024)
• Genetic nurture effects for alcohol use disorder. (2023)
• The Collaborative Study on the Genetics of Alcoholism: Overview. (2023)
• Pervasive Downward Bias in Estimates of Liability-Scale Heritability in Genome-wide Association Study Meta-analysis: A Simple Solution. (2023)
• Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses. (2023)
• Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals. (2023)
• Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users. (2023)
• Genetic Influences on the Developing Young Brain and Risk for Neuropsychiatric Disorders. (2023)
• The Promise and Peril of Genetics. (2022)
• Gene-based polygenic risk scores analysis of alcohol use disorder in African Americans. (2022)
• Shared genetic architecture across psychiatric disorders. (2021)
• Polygenic risk scores for alcohol involvement relate to brain structure in substance-naïve children: Results from the ABCD study. (2021)
• Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions. (2021)
• Placental genomic risk scores and early neurodevelopmental outcomes. (2021)
• Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. (2021)
• Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction. (2021)
• Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. (2021)
• Genetics of substance use disorders in the era of big data. (2021)
• Interpretation of risk loci from genome-wide association studies of Alzheimer's disease. (2020)
• ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries. (2020)
• Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. (2020)
• Defining the Genetic, Genomic, Cellular, and Diagnostic Architectures of Psychiatric Disorders. (2019)
• Sex differences in the genetic architecture of obsessive-compulsive disorder. (2019)
• Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. (2019)
• Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies. (2019)
• Identification of common genetic risk variants for autism spectrum disorder. (2019)
• Psychosocial moderation of polygenic risk for cannabis involvement: the role of trauma exposure and frequency of religious service attendance. (2019)
• Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences. (2019)
• Genome-wide association analysis links multiple psychiatric liability genes to oscillatory brain activity. (2018)
• The Gene Encoding Protocadherin 9 (PCDH9), a Novel Risk Factor for Major Depressive Disorder. (2018)
• Psychiatric Genomics: An Update and an Agenda. (2018)
• Critical Issues in the Inclusion of Genetic and Epigenetic Information in Prevention and Intervention Trials. (2018)
• Elevated polygenic burden for autism is associated with differential DNA methylation at birth. (2018)
• Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood. (2018)
• Genetic studies of alcohol dependence in the context of the addiction cycle. (2017)
• Effects of Antenatal Maternal Depressive Symptoms and Socio-Economic Status on Neonatal Brain Development are Modulated by Genetic Risk. (2017)
• Genome-Wide Association Studies of a Broad Spectrum of Antisocial Behavior. (2017)
• Translating genome-wide association findings into new therapeutics for psychiatry. (2016)
• G = E: What GWAS Can Tell Us about the Environment. (2016)
• Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. (2016)
• Social cognition as an RDoC domain. (2016)
• Alcohol Dependence Genetics: Lessons Learned From Genome-Wide Association Studies (GWAS) and Post-GWAS Analyses. (2015)
• The PsychENCODE project. (2015)
• Recent genetic findings in schizophrenia and their therapeutic relevance. (2015)
• An introductory review of parallel independent component analysis (p-ICA) and a guide to applying p-ICA to genetic data and imaging phenotypes to identify disease-associated biological pathways and systems in common complex disorders. (2015)
• Candidate gene-environment interaction research: reflections and recommendations. (2015)
• Evaluating historical candidate genes for schizophrenia. (2015)
• Genetics and genomics of psychiatric disease. (2015)
• The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. (2014)
• Heritability and molecular-genetic basis of the P3 event-related brain potential: a genome-wide association study. (2014)
• Heritability and molecular-genetic basis of resting EEG activity: a genome-wide association study. (2014)
• Cannabis controversies: how genetics can inform the study of comorbidity. (2014)
• The impact of environmental factors in severe psychiatric disorders. (2014)
• A mega-analysis of genome-wide association studies for major depressive disorder. (2013)
• Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. (2012)
• CNVs: harbingers of a rare variant revolution in psychiatric genetics. (2012)
• Gene-environment interaction in psychological traits and disorders. (2011)
• Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies. (2011)
• Association study of 182 candidate genes in anorexia nervosa. (2010)
• The psychiatric GWAS consortium: big science comes to psychiatry. (2010)
• Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. (2009)
• Genomewide association studies: history, rationale, and prospects for psychiatric disorders. (2009)
• Genome-wide association studies in ADHD. (2009)

Merged raw entities (12)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.